Prolonged modulation of FGF-2 expression in astrocytic cultures induced by O,O′-diacetyl-apomorphine

Biochemical and Biophysical Research Communications

Volumn 369, Issue 3, 2008, Pages 824-829

  He, Xiaochun ^a   Wang, Dakui ^b,d   Zhang, Xinhua ^c,d   Li, Aiqun ^c   Gu, Xiaosong ^d   Ding, Fei ^d   Zhou, Jiawei ^b  

^a Nantong Science and Technology College   (China)

^b Chinese Academy of Sciences   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^d NANTONG UNIVERSITY   (China)

Author keywords

Apomorphine; Astrocytes; Chemical synthesis; Fibroblast growth factor 2; O,O Diacetyl apomorphine

Indexed keywords

APOMORPHINE; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; O,O' DIACETYLAPOMORPHINE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INDUCTION; NEWBORN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; ASTROCYTES; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; OXIDATION-REDUCTION; PRODRUGS; RATS; SIGNAL TRANSDUCTION; UP-REGULATION;

PARKINSONIA;

EID: 41149111284     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.082     Document Type: Article

References (19)

1. Vila M., Jackson-Lewis V., Guegan C., Wu D.C., Teismann P., Choi D.K., Tieu K., and Przedborski S. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14 (2001) 483-489
2. Cao L., Liu L., Chen Z.Y., Wang L.M., Ye J.L., Qiu H.Y., Lu C.L., and He C. Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain 127 (2004) 535-549
3. Albeck D.S., Hoffer B.J., Quissell D., Sanders L.A., Zerbe G., and Granholm A.C. A non-invasive transport system for GDNF across the blood-brain barrier. Neuroreport 8 (1997) 2293-2298
4. Kyriazis M. Neuroprotective, anti-apoptotic effects of apomorphine. J. Anti Aging Med. 6 (2003) 21-28
5. Zhang A., Neumeyer J.L., and Baldessarini R.J. Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem. Rev. 107 (2007) 274-302
6. Roceri M., Molteni R., Fumagalli F., Racagni G., Gennarelli M., Corsini G., Maggio R., and Riva M. Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum. J. Neurochem. 76 (2001) 990-997
7. Ohta M., Mizuta I., Ohta K., Nishimura M., Mizuta E., Hayashi K., and Kuno S. Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes. Biochem. Biophys. Res. Commun. 272 (2000) 18-22
8. Guo H., Tang Z., Yu Y., Xu L., Jin G., and Zhou J. Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures. Eur. J. Neurosci. 16 (2002) 1861-1870
9. Li A., Guo H., Luo X., Sheng J., Yang S., Yin Y., Zhou J., and Zhou J. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J. 20 (2006) 1263-1265
10. Csutoras C., Zhang A., Zhang K., Kula N.S., Baldessarini R.J., and Neumeyer J.L. Synthesis and neuropharmacological evaluation of R(-)-N-alkyl-11-hydroxynoraporphines and their esters. Bioorg. Med. Chem. 12 (2004) 3553-3559
11. Garrido J.M., Delerue-Matos C., Borges M.F., Macedo T.R., and Oliveira-Brett A.M. Oxidative behaviour of apomorphine and its metabolites. Bioelectrochemistry (Amsterdam, Netherlands) 55 (2002) 113-114
12. Borgman R.J. Prolonged apomorphine-like behavioural effects of apomorphine esters. Neuropharmacology 15 (1976) 471-478
13. Borgman R.J., Smith R.V., and Keiser J.E. The acetylation of apomorphine. An improved method for the selective preparation of diacetylapomorphine utilizing trifluoroacetic acid/acetyl bromide. J. Med. Chem. 18 (1975) 249-250
14. Borgman R.J., Baldessarini R.J., and Walton K.G. Diester derivatives as apomorphine prodrugs. J. Med. Chem. 19 (1976) 717-719
15. Menet V., Gimenez y Ribotta M., Chauvet N., Drian M.J., Lannoy J., Colucci-Guyon E., and Privat A. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J. Neurosci. 21 (2001) 6147-6158
16. Manevich Y., Sweitzer T., Pak J.H., Feinstein S.I., Muzykantov V., and Fisher A.B. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc. Natl. Acad. Sci. USA 99 (2002) 11599-11604
17. Neumeyer J.L., Arana G.W., Law S.J., Lamont J.S., Kula N.S., and Baldessarini R.J. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines. J. Med. Chem. 24 (1981) 1440-1445
18. Kristoffersson J., Svensson L.A., and Tegner K. Drug latentiation of terbutaline. In vitro serum esterase catalyzed hydrolysis of a series of acyl-substituted mono- and diesters of terbutaline. Acta Pharm. Suec. 11 (1974) 427-438
19. Saari W.S., and King S.W. Synthesis and biological activity of (6aS)-10,11-dihydroxyaporphine, the optical antipode of apomorphine. J. Med. Chem. 16 (1973) 171-172